Quantcast

Unique Pipeline Study on the Central Nervous System With Focus on Memory Impairment

November 6, 2008

Research and Markets (http://www.researchandmarkets.com/research/719269/central_nervous_sy) has announced the addition of the “Central Nervous System – Memory Impairment” report to their offering.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

— Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.

— Keep track of your competitors and partners by better understanding their product pipeline.

— Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.

— Maintain a critical competitive advantage.

Key Topics Covered:

 - Memory Impairment Pipeline Overview - - % of Projects (By Phase of Development) - - No. of Projects by Phase of Development - - Marketed Products Vs. Pipeline Products Company Overview - Pipeline Projects - - Company Overview - Pipeline Projects - Full Pipeline View - - Pre Clinical Pipeline View - - Phase I Pipeline View - - Phase II Pipeline View - - Phase III Pipeline View - - On the Market Pipeline View - - Discovery/Development Pipeline View Companies mentioned: - Top Companies in late stage Memory Impairment Projects - - Allon Therapeutics Inc. - - Accera, Inc. - - AstraZeneca Plc - - Amarin Corporation plc - - Eli Lilly & Co - - Cephalon Inc - - Inflazyme Pharmaceuticals Ltd. - - Helicon Therapeutics, Inc - - Lexicon Pharmaceuticals, Inc - - Ipsen Ltd - - Pharmos Corporation - - Memory Pharmaceuticals Corp - - SERVIER - - Saegis Pharmaceuticals, Inc. - - Targacept Inc - - Symphony Icon, Inc. - Top Companies in early stage Memory Impairment Projects - - Amarin Corporation plc - - Abbott Laboratories - - Avera Pharmaceuticals, Inc. - - AstraZeneca Plc - - DrugAbuse Sciences, Inc. - - BTG plc - - EPIX Pharmaceuticals Inc - - Eli Lilly & Co - - Helicon Therapeutics, Inc - - Esteve - - Mimetogen Pharmaceuticals Inc. - - Krenitsky Pharmaceuticals Inc. - - Pharmaxon - - Nyxis Neurotherapies, Inc. - - Roche Holdings Ltd - - Proteome Systems Limited - - Targacept Inc - - Suven Life Sciences Limited - - Xytis, Inc. - - Vasogen Inc 

For more information visit http://www.researchandmarkets.com/research/719269/central_nervous_sy

Source: Life Science Analytics




comments powered by Disqus